Herborium Group Inc HBRM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $1.09 Mil
- Volume/Avg
- 217,980 / 3.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Herborium Group Inc provides natural, & complementary healthcare-related products to consumers & healthcare professionals seeking alternative answers to the management of healthcare issues not currently met by standard Western medicine. Its focus is on developing, licensing, & marketing proprietary, botanical-based medicinal products, targeting unmet medical needs. Its products are botanical supplements comprised of herbal formulations, referred as botanical therapeutics. Substantially all of the company's revenue has been derived from the sale of AcnEase through its corporate website. The Company responds to both consumer & healthcare professionals demand for safe, efficacious, all-natural medicinal options for the treatment and prevention of selected diseases & health concerns.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1
- Website
- https://www.herborium.com
Valuation
|
Metric
|
HBRM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
HBRM
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.03 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
HBRM
|
|---|---|
Return on Assets (Normalized) | −566.94% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Wjqsymkcd | Shpy | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Vmccrxdj | Hthvdrn | $70.8 Bil | |
HLN
| Haleon PLC ADR | Cqyjqryj | Xkpm | $37.7 Bil | |
VTRS
| Viatris Inc | Gzncgrdm | Gnpfm | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ycxxkkd | Cjpt | $12.5 Bil | |
CTLT
| Catalent Inc | Lgmhtkh | Wrtnqnd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Xsnhxmwy | Tgcd | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Kdplrydm | Hdmbb | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Drqqzsnym | Xswfy | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Cwrtqfsj | Cdpk | $2.9 Bil |